Protext Mobility, Inc. (OTC: TXTM) is thrilled to share a transformative update, advancing uplisting readiness with a preliminary Deloitte engagement

FORT LAUDERDALE, Fla., Jan. 20, 2026 (GLOBE NEWSWIRE) — Protext Mobility, Inc. (OTC: TXTM) (“Protext” “TXTM” or the “Company”) is thrilled to share a transformative update that underscores its strategic execution, operational...

Protext Mobility, Inc. (OTC: TXTM) Provides Shareholder Update

FORT LAUDERDALE, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) — Protext Mobility, Inc. (OTC: TXTM) (“Protext” or the “Company”) is thrilled to share a transformative update that underscores its strategic execution, operational excellence, and...

Protext Mobility, Inc. (OTC: TXTM) Announces Strategic TruLeaf Partnership & Next-Level Innovation

FORT LAUDERDALE, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) — Protext Mobility, Inc. (OTC: TXTM) (“Protext” or the “Company”) is proud to announce a strategic Letter of Intent (LOI) with TruLeaf, marking a pivotal moment in the company’s...

Protext Mobility, Inc. (OTC: TXTM) Announces Launch Phase of Its Next-Generation Investor Relations Suite and Corporate Website Modernization – Ushering in a New Era of Transparency, Innovation, and Shareholder Confidence

NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) — Protext Mobility, Inc. (OTC: TXTM), an emerging leader in botanical-based biotechnology and NANOTECHNOLOGY, today announced the launch and completion phase of its next-generation Investor Relations (“IR”)...

Protext Mobility, Inc. (OTC: TXTM) Announces CEO Statement Following Removal of Caveat Emptor Designation

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) — Protext Mobility, Inc. (OTC: TXTM) (“TXTM”), an emerging biotechnology company pioneering advancements in plant-based therapeutics, today released an official statement from Chief Executive Officer Mr. Dylon...